Asarina Pharma is a company that develops treatments for premenstrual dysphoric syndrome and menstrual-related diseases. It provides Sepranolone, a non-hormonally active compound that inhibits the disease provoking effect of the progesterone metabolite, allopregnanolone, in women suffering from PMDD.